Last reviewed · How we verify
Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.
A Phase 1, Open Label, Parallel-Cohort, Randomized, Fixed Sequence Study To Evaluate The Pharmacokinetic Drug Drug Interaction Between PF-04965842 and Fkuvoxamine (cohort 1) or Fluconazole (Cohort 2) in healthy subjects.
Details
| Lead sponsor | Pfizer |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | Wed Sep 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dermatitis, Atopic
Interventions
- Period 1 - Day 1: PF-04965842 administered
- Period 2: Cohort 1: Fluvoxamine & PF-04965842
- Period 2: Cohort 2: Fluconazole & PF-04965842
Countries
Belgium